|
1
|
Liu YJ, Lu SH, Xu B, Yang RC, Ren Q, Liu
B, Li B, Lu M, Yan FY, Han ZB and Han ZC: Hemangiopoietin, a novel
human growth factor for the primitive cells of both hematopoietic
and endothelial cell lineages. Blood. 103:4449–4456. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Flannery CR, Hughes CE, Schumacher BL,
Tudor D, Aydelotte MB, Kuettner KE and Caterson B: Articular
cartilage superficial zone protein (SZP) is homologous to
megakaryocyte stimulating factor precursor and is a multifunctional
proteoglycan with potential growth-promoting, cytoprotective, and
lubricating properties in cartilage metabolism. Biochem Biophys Res
Commun. 254:535–541. 1999. View Article : Google Scholar
|
|
3
|
Ikegawa S, Sano M, Koshizuka Y and
Nakamura Y: Isolation, characterization and mapping of the mouse
and human PRG4 (proteoglycan 4) genes. Cytogenet Cell Genet.
90:291–297. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jay GD, Tantravahi U, Britt DE, Barrach HJ
and Cha CJ: Homology of lubricin and superficial zone protein
(SZP): products of megakaryocyte stimulating factor (MSF) gene
expression by human synovial fibroblasts and articular chondrocytes
localized to chromosome 1q25. J Orthop Res. 19:677–687. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rees SG, Davies JR, Tudor D, Flannery CR,
Hughes CE, Dent CM and Caterson B: Immunolocalisation and
expression of proteoglycan 4 (cartilage superficial zone
proteoglycan) in tendon. Matrix Biol. 21:593–602. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Panagopoulos I, Mertens F, Isaksson M and
Mandahl N: Expression of DOL54 is not restricted to myxoid
liposarcomas with the FUS-DDIT3 chimera but is found in various
sarcomas. Oncol Rep. 12:107–110. 2004.PubMed/NCBI
|
|
7
|
Zhan M and Han ZC: Hemangiopoietin
inhibits apoptosis of MO7e leukemia cells through
phosphatidylinositol 3-kinase-AKT pathway. Biochem Biophys Res
Commun. 317:198–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu ZS, Liu YJ, Lv LL, Han ZB, He R, Lu SH,
Wang T, Xu B, Chen ZZ and Han ZC: Bone marrow stromal cells
transduced with human hemangiopoietin gene support hematopoiesis in
vitro. Haematologica. 90:157–165. 2005.PubMed/NCBI
|
|
9
|
Guo NH, Krutzsch HC, Nègre E, Zabrenetzky
VS and Roberts DD: Heparin-binding peptides from the type I repeats
of thrombospondin. Structural requirements for heparin binding and
promotion of melanoma cell adhesion and chemotaxis. J Biol Chem.
267:19349–19355. 1992.PubMed/NCBI
|
|
10
|
Shimakura Y, Kawada H, Ando K, Sato T,
Nakamura Y, Tsuji T, Kato S and Hotta T: Murine stromal cell line
HESS-5 maintains reconstituting ability of ex vivo-generated
hematopoietic stem cells from human bone marrow and
cytokine-mobilized peripheral blood. Stem Cells. 18:183–189. 2000.
View Article : Google Scholar
|
|
11
|
Völker W, Hess S, Vischer P and Preissner
KT: Binding and processing of multimeric vitronectin by vascular
endothelial cells. J Histochem Cytochem. 41:1823–1832.
1993.PubMed/NCBI
|
|
12
|
Seiffert D: The glycosaminoglycan binding
site governs ligand binding to the somatomedin B domain of
vitronectin. J Biol Chem. 272:9971–9978. 1997.PubMed/NCBI
|
|
13
|
Deng G, Curriden SA, Hu G, Czekay RP and
Loskutoff DJ: Plasminogen activator inhibitor-1 regulates cell
adhesion by binding to the somatomedin B domain of vitronectin. J
Cell Physiol. 189:23–33. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zanetti A, Conforti G, Hess S,
Martìn-Padura I, Ghibaudi E, Preissner KT and Dejana E: Clustering
of vitronectin and RGD peptides on microspheres leads to engagement
of integrins on the luminal aspect of endothelial cell membrane.
Blood. 84:1116–11123. 1994.PubMed/NCBI
|
|
15
|
Burke C, Mayo KH, Skubitz AP and Furcht
LT: 1H NMR and CD secondary structure analysis of cell adhesion
promoting peptide F-9 from laminin. J Biol Chem. 266:19407–19412.
1991.PubMed/NCBI
|
|
16
|
Bittorf SV, Williams EC and Mosher DF:
Alteration of vitronectin. Characterization of changes induced by
treatment with urea. J Biol Chem. 268:24838–24846. 1993.PubMed/NCBI
|
|
17
|
Zhuang P, Chen AI and Peterson CB: Native
and multimeric vitronectin exhibit similar affinity for heparin.
Differences in heparin binding properties induced upon denaturation
are due to self-association into a multivalent form. J Biol Chem.
272:6858–6867. 1997. View Article : Google Scholar
|
|
18
|
Preissner KT and Jenne D: Structure of
vitronectin and its biological role in haemostasis. Thromb Haemost.
66:123–132. 1991.PubMed/NCBI
|
|
19
|
Zhuang P, Blackburn MN and Peterson CB:
Characterization of the denaturation and renaturation of human
plasma vitronectin. I Biophysical characterization of protein
unfolding and multimerization. J Biol Chem. 271:14323–14332. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guex N and Peitsch MC: SWISS-MODEL and the
Swiss-Pdb Viewer: an environment for comparative protein modeling.
Electrophoresis. 18:2714–2723. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Horn NA, Hurst GB, Mayasundari A,
Whittemore NA, Serpersu H and Peterson CB: Assignment of the four
disulfides in the N-terminal somatomedin B domain of native
vitronectin isolated from human plasma. J Biol Chem.
279:35867–35878. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kamikubo Y, Okumura Y and Loskutoff DJ:
Identification of the disulfide bonds in the recombinant
somatomedin B domain of human vitronectin. J Biol Chem.
277:27109–27119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamikubo Y, De Guzman R, Kroon G, Curriden
S, Neels JG, Churchill MJ, Dawson P, Ołdziej S, Jagielska A,
Scheraga HA, Loskutoff DJ and Dyson HJ: Disulfide bonding
arrangements in active forms of the somatomedin B domain of human
vitronectin. Biochemistry. 43:6519–6534. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gijsbers R, Ceulemans H and Bollen M:
Functional characterization of the non-catalytic ectodomains of the
nucleotide pyrophosphatase/phosphodiesterase NPP1. Biochem J.
371:321–330. 2003. View Article : Google Scholar
|
